EntryPoint Capital’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,654
| Closed | -$56.1K | – | 845 |
|
|
2025
Q1 | $56.1K | Buy |
+12,654
| New | +$56.1K | 0.03% | 642 |
|
|
2024
Q4 | – | Sell |
-17,071
| Closed | -$224K | – | 996 |
|
|
2024
Q3 | $224K | Buy |
17,071
+10,919
| +177% | +$144K | 0.13% | 395 |
|
|
2024
Q2 | $74.3K | Buy |
+6,152
| New | +$74.3K | 0.11% | 428 |
|
|
2024
Q1 | – | Sell |
-41,949
| Closed | -$286K | – | 1805 |
|
|
2023
Q4 | $286K | Buy |
+41,949
| New | +$286K | 0.27% | 29 |
|